Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6300 W Parker Rd
Ste 224
Plano, TX 75093Phone+1 469-574-0464Fax+1 469-574-0471
Education & Training
University of Texas Southwestern Medical CenterFellowship, Nephrology, 2006 - 2008
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2005
Beijing Medical UniversityClass of 1992
Certifications & Licensure
TX State Medical License 2005 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011
Clinical Trials
- AmB Dose for Cryptococcal Meningitis Start of enrollment: 2020 Jan 02
Publications & Presentations
PubMed
- Corrigendum to "Adiponectin ameliorates hypoperfusive cognitive deficits by boosting a neuroprotective microglial response" [Prog. Neurobiol. 205 (2021) 102125].Wanying Miao, Liyuan Jiang, Fei Xu, Junxuan Lyu, Xiaoyan Jiang
Progress in Neurobiology. 2024-10-01 - 3D vector MR elastography applications in small organs.Vitaliy Atamaniuk, Łukasz Hańczyk, Jun Chen, Andrii Pozaruk, Marzanna Obrzut
Magnetic Resonance Imaging. 2024-10-01 - Gene cloning, expression and performance validation of nitric oxide dismutase.Mengwei Bai, Jiamei He, Fengzhen Zheng, Sini Lv, Zeyu Wang
The Science of the Total Environment. 2024-07-20
Journal Articles
- Loss of Function of NF1 Is a Mechanism of Acquired Resistance to Endocrine Therapy in Lobular Breast CancerA V Lee, Y X Feng, J Chung, S Ali, J Chen, J S Ross, Annals of Oncology
- Tissue Plasminogen Activator Promotes White Matter Integrity and Functional Recovery in a Murine Model of Traumatic Brain InjuryJun Chen, MD, Proceedings of the National Academy of Sciences
Press Mentions
Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV InfectionSeptember 15th, 2022- Fast-Acting Immune Cells Provide Powerful Protection Against StrokeAugust 1st, 2022
- Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV InfectionJuly 3rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
